Showing 4,181 - 4,200 results of 11,885 for search '(( significantly ((we decrease) OR (teer decrease)) ) OR ( significant level decrease ))', query time: 0.57s Refine Results
  1. 4181

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  2. 4182

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  3. 4183

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  4. 4184

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  5. 4185

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”
  6. 4186
  7. 4187
  8. 4188
  9. 4189

    Supplementary file 1_Investigating the feasibility of machine learning to guide personalized red blood cell (RBC) transfusion: analyzing the heterogeneity of RBC transfusion in sep... by Penglei Yang (8090156)

    Published 2025
    “…Background<p>This study utilized the causal forest algorithm to explore the heterogeneity of treatment effects of low-dose red blood cell (RBC) transfusion on the 90-day survival rate of sepsis patients with hemoglobin (Hb) levels of 7–9 g/dL to develop personalized transfusion strategies.…”
  10. 4190

    Primers for qPCR. by Kaitao Zhao (3617825)

    Published 2025
    “…Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  11. 4191

    Antibodies used for western blotting. by Kaitao Zhao (3617825)

    Published 2025
    “…Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  12. 4192

    Target sequences of siRNAs. by Kaitao Zhao (3617825)

    Published 2025
    “…Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  13. 4193

    Plasmids information. by Kaitao Zhao (3617825)

    Published 2025
    “…Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  14. 4194

    Raw data. by Kaitao Zhao (3617825)

    Published 2025
    “…Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  15. 4195

    Graphical abstract regarding program development. by Ana Beato (20489933)

    Published 2024
    “…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”
  16. 4196

    Phases of the intervention program. by Ana Beato (20489933)

    Published 2024
    “…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”
  17. 4197

    Influence of Postsynthetic Ligand Exchange in ZIF‑7 on Gate-Opening Pressure and CO<sub>2</sub>/CH<sub>4</sub> Mixture Separation by Lukas W. Bingel (9371686)

    Published 2024
    “…The field of flexible metal–organic frameworks (MOFs) has garnered significant attention from researchers due to their potential for gas storage and capture applications. …”
  18. 4198

    Consort diagram. by Ana Beato (20489933)

    Published 2024
    “…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”
  19. 4199

    Influence of Postsynthetic Ligand Exchange in ZIF‑7 on Gate-Opening Pressure and CO<sub>2</sub>/CH<sub>4</sub> Mixture Separation by Lukas W. Bingel (9371686)

    Published 2024
    “…The field of flexible metal–organic frameworks (MOFs) has garnered significant attention from researchers due to their potential for gas storage and capture applications. …”
  20. 4200

    Characteristics of the sample. by Ana Beato (20489933)

    Published 2024
    “…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”